This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Learn why balancing short and long term goals leads to steadier progress and fewer stressful financial decisions.
28,499 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Microsoft stock is drawing fresh attention as investors weigh AI demand against execution risk. With a trailing P/E n...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
February brought a sharp drop for Upstart as investors weighed margins, product risk, and leadership changes. This de...
When a company's top medical officer sells a large block and leaves with a zero direct stake, investors notice. This ...
A convincing fake bank call sent a Virginia resident on a cash handoff, revealing how scammers use authority and urge...
As Warren Buffett steps back, Greg Abel’s potential move to buy a stock Buffett loves has investors buzzing. This art...
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Investors watched spacemobile stock crushed thursday move sharply as AT&T, Verizon, and T-Mobile signaled a bold sate...
A once-hot cybersecurity stock has fallen 40%, yet a large investor just increased exposure. This guide breaks down w...
A veteran market strategist warns that the next six to twelve months could bring volatility as a flood of tech IPOs t...